Dihydroberberine
Dihydroberberine has anti-atherosclerotic anti-inflammatory hypolipidemic and antitumor activities. It inhibits human ether-a-go-go-related gene (hERG) channels and remarkably reduces Hsp90 expression and its interaction with hERG.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
337.4
Molecular Formula
C20H19NO4
Notes
Research use only, not for human use.
Receptor
HERG| HSP90
CAS Number
483-15-8
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
